Cargando…

The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis

BACKGROUND AND STUDY AIMS: It is unclear to what extent EUS influences the surgical management of patients with pancreatic adenocarcinoma. This systematic review sought to determine if EUS evaluation improves the identification of unresectable disease among adults with pancreatic adenocarcinoma. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	James, Paul D., Meng, Zhao Wu, Zhang, Mei, Belletrutti, Paul J., Mohamed, Rachid, Ghali, William, Roberts, Derek J., Martel, Guillaume, Heitman, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358870/ https://www.ncbi.nlm.nih.gov/pubmed/28319148 http://dx.doi.org/10.1371/journal.pone.0173687

Ejemplares similares

An Unusual Case of Pancreatic Metastasis from Squamous Cell Carcinoma of the Lung Diagnosed by EUS-Guided Fine Needle Biopsy
por: Ishikawa, Takuya, et al.
Publicado: (2017)

Novel EUS-guided microwave ablation of an unresectable pancreatic neuroendocrine tumor
por: Robles-Medranda, Carlos, et al.
Publicado: (2022)

The incremental benefit of EUS for the identification of malignancy in indeterminate extrahepatic biliary strictures: A systematic review and meta-analysis
por: Chiang, Albert, et al.
Publicado: (2019)

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
por: Yanagimoto, Hiroaki, et al.
Publicado: (2020)

Simultaneous Duodenal Metal Stent Placement and EUS-Guided Choledochoduodenostomy for Unresectable Pancreatic Cancer
por: Kawakubo, Kazumichi, et al.
Publicado: (2012)

Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic cancer
por: Jiang, Jieling, et al.
Publicado: (2021)

Re-defining the role of EUS in pancreatic adenocarcinoma in 2017
por: Arcidiacono, Paolo G.
Publicado: (2017)

Unresectable Pancreatic Adenocarcinoma: Eight Years Later
por: Smiley, Kate, et al.
Publicado: (2016)

Clinical outcomes of EUS-guided radiofrequency ablation for unresectable pancreatic cancer: A prospective observational study
por: Oh, Dongwook, et al.
Publicado: (2022)

Clinical Outcomes of EUS-Guided Choledochoduodenostomy for Biliary Drainage in Unresectable Pancreatic Cancer: A Case Series
por: Hristov, Bozhidar, et al.
Publicado: (2023)

“Invisible” pancreatic masses identified by EUS by the “ductal cutoff sign”
por: Fairley, Kimberly J., et al.
Publicado: (2019)

Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis
por: Mataki, Yuko, et al.
Publicado: (2021)

Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?
por: Rosumeck, Nathalie, et al.
Publicado: (2021)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: EUS oriented
por: Iordache, Sevastiţa, et al.
Publicado: (2017)

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
por: Yan, Brian M., et al.
Publicado: (2021)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

A124 INITIAL EXPERIENCES AND OUTCOMES IN LAUNCHING AN ESD PROGRAM IN CANADA
por: Jeyalingam, T, et al.
Publicado: (2022)

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma
por: Thosani, Nirav, et al.
Publicado: (2022)

Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology
por: Pedrosa, L., et al.
Publicado: (2023)

Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions
por: Sugimoto, Mitsuru, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma
por: SAIF, MUHAMMAD WASIF, et al.
Publicado: (2014)

Which is the Best Imaging Method in Pancreatic Adenocarcinoma Diagnosis and Staging - CT, MRI or EUS?
por: COSTACHE, M.I., et al.
Publicado: (2017)

EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial
por: Yoon, Won Jae, et al.
Publicado: (2020)

EUS-guided antegrade pancreatic duct access: Burning questions
por: Bronswijk, Michiel, et al.
Publicado: (2023)

Involved-Field Radiation Therapy for Patients With Unresectable Pancreatic Adenocarcinomas: Failure Pattern Analysis
por: Fogaroli, Ricardo C, et al.
Publicado: (2023)

Does Ablation Technique Utilized in the Management of Unresectable Locally Advanced Pancreatic Adenocarcinoma?
por: Pezzilli, Raffaele, et al.
Publicado: (2010)

The best approach for sampling of pancreatic neuroendocrine tumors – EUS-FNA or EUS-FNB?
por: Hedenström, Per
Publicado: (2019)

Endoscopic ultrasound (EUS) and the management of pancreatic cancer
por: Yousaf, Muhammad Nadeem, et al.
Publicado: (2020)

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
por: Hirooka, Yoshiki, et al.
Publicado: (2018)

Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic cancer (PEACE): A study protocol
por: Săftoiu, Adrian, et al.
Publicado: (2019)

Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma
por: Dyer, Brandon A, et al.
Publicado: (2015)

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
por: Kornek, G V, et al.
Publicado: (2000)

Chemoradiation After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma is it of Proven Benefit?
por: Garden, O. J.
Publicado: (1999)

Incremental Learning with SVM for Multimodal Classification of Prostatic Adenocarcinoma
por: García Molina, José Fernando, et al.
Publicado: (2014)

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
por: Hosein, Peter J, et al.
Publicado: (2012)

EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review
por: Li, Mao, et al.
Publicado: (2021)

Second-Look Operation for Unresectable Pancreatic Ductal Adenocarcinoma at a High-Volume Center
por: Michalski, Christoph W., et al.
Publicado: (2007)

Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability
por: Shi, Hao-Jun, et al.
Publicado: (2016)

Efficacy of primary drainage by endoscopic ultrasound‐guided biliary drainage for unresectable pancreatic adenocarcinoma
por: Tanikawa, Tomohiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cf82becpidpvmuqstprtib7krr